Bevacizumab versus triamcinolone for persistent diabetic macular edema: a randomized clinical trial (2020)
- Authors:
- USP affiliated authors: MESSIAS, ANDRÉ MÁRCIO VIEIRA - FMRP ; SIQUEIRA, RUBENS CAMARGO - FMRP ; JORGE, RODRIGO - FMRP ; RODRIGUES JUNIOR, MURILO WENDEBORN - FMRP
- Unidade: FMRP
- DOI: 10.1007/s00417-019-04564-z
- Subjects: ACUIDADE VISUAL; DIABETES MELLITUS; OFTALMOPATIAS
- Keywords: Diabetic macular edema; Intravitreal injection; Bevacizumab; Triamcinolone
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Heidelberg
- Date published: 2020
- Source:
- Título: Graefe's Archive for Clinical and Experimental Ophthalmology
- ISSN: 0721-832X
- Volume/Número/Paginação/Ano: v. 258, n. 3, p. 479-490, 2020
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
RODRIGUES JÚNIOR, Murilo Wendeborn et al. Bevacizumab versus triamcinolone for persistent diabetic macular edema: a randomized clinical trial. Graefe's Archive for Clinical and Experimental Ophthalmology, v. 258, n. 3, p. 479-490, 2020Tradução . . Disponível em: https://doi.org/10.1007/s00417-019-04564-z. Acesso em: 28 fev. 2026. -
APA
Rodrigues Júnior, M. W., Cardillo, J. A., Messias, A. M. V., Siqueira, R. C., Scott, I. U., & Jorge, R. (2020). Bevacizumab versus triamcinolone for persistent diabetic macular edema: a randomized clinical trial. Graefe's Archive for Clinical and Experimental Ophthalmology, 258( 3), 479-490. doi:10.1007/s00417-019-04564-z -
NLM
Rodrigues Júnior MW, Cardillo JA, Messias AMV, Siqueira RC, Scott IU, Jorge R. Bevacizumab versus triamcinolone for persistent diabetic macular edema: a randomized clinical trial [Internet]. Graefe's Archive for Clinical and Experimental Ophthalmology. 2020 ; 258( 3): 479-490.[citado 2026 fev. 28 ] Available from: https://doi.org/10.1007/s00417-019-04564-z -
Vancouver
Rodrigues Júnior MW, Cardillo JA, Messias AMV, Siqueira RC, Scott IU, Jorge R. Bevacizumab versus triamcinolone for persistent diabetic macular edema: a randomized clinical trial [Internet]. Graefe's Archive for Clinical and Experimental Ophthalmology. 2020 ; 258( 3): 479-490.[citado 2026 fev. 28 ] Available from: https://doi.org/10.1007/s00417-019-04564-z - Clinical studies using stem cells for treatment of retinal diseases: state of the art
- Intravitreal use of a Bone Marrow Mononuclear Fraction (BMMF) containing CD34+ cells in patients with Stargardt type macular dystrophy
- Intravitreal ranibizumab for persistent new vessels in diabetic retinopathy
- Retinal safety and efficacy of a dexamethasone biodegradable implant to treat macular edema associated to retinal vein occlusion: a phase I/II clinical trial
- Intravitreal use of bone marrow mononuclear fraction containing CD34+ stem cells in patients with atrophic age-related macular degeneration
- Intravitreal bevacizumab or triamcinolone combined with macular laser photocoagulation for diabetic macular edema: preliminary results
- Ranibizumabe intravítreo no pré-operatório de vitrectomia em pacientes diabéticos com descolamento de retina tracional
- Intravitreal autologous bone marrow derived stem cells in dry age-related macular degeneration
- Intravitreal autologous bone marrow derived stem cells in ischemic maculopathy
- Diabetic macular edema treatment with bevacizumab vs. ranibizumab: a microperimetry study
Informações sobre o DOI: 10.1007/s00417-019-04564-z (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003081997.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
